Search Results

There are 3276 results for: content related to: Tardive akathisia: An analysis of clinical features and response to open therapeutic trials

  1. Acute Drug-Induced Akathisia

    Drug Induced Movement Disorders, Second Edition

    Lenard A. Adler, John Rotrosen, Burt Angrist, Pages: 140–173, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch7

  2. Restless Legs Syndrome and Akathisia in Parkinson's Disease

    Parkinson's Disease: Non-Motor and Non-Dopaminergic Features

    Alex Iranzo, Cynthia L. Comella, Pages: 333–345, 2011

    Published Online : 27 JUN 2011, DOI: 10.1002/9781444397970.ch30

  3. Treatment of Acute Neuroleptic-Induced Movement Disorders

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 14, Issue 5, September-October 1994, Pages: 543–560, Dr. Margaret E. Tonda and Dr. Sally K. Guthrie

    Version of Record online : 18 JAN 2012, DOI: 10.1002/j.1875-9114.1994.tb02851.x

  4. Neuroleptic-Induced Tardive Dyskinesia Variants

    Drug Induced Movement Disorders, Second Edition

    Frank Skidmore, William J. Weiner, Robert Burke, Pages: 257–284, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch10

  5. Risk and Severity of Akathisia Following Administration of Metoclopramide in the Emergency Department

    Journal of Pharmacy Practice and Research

    Volume 36, Issue 3, September 2006, Pages: 194–198, Fiona HP Leow, Jonathan C Knott, Fariza Abu Hassan, David McD Taylor and Ruwangi Udayasiri

    Version of Record online : 13 APR 2015, DOI: 10.1002/j.2055-2335.2006.tb00606.x

  6. Withdrawal akathisia: Case reports and a proposed classification of chronic akathisia

    Movement Disorders

    Volume 9, Issue 2, 1994, Pages: 188–192, Dr. Anthony E. Lang

    Version of Record online : 12 OCT 2004, DOI: 10.1002/mds.870090211

  7. Opioid responsiveness in patients with neuroleptic-induced akathisia

    Movement Disorders

    Volume 1, Issue 2, 1986, Pages: 119–127, Dr. Arthur Walters, Wayne Hening, Sudhansu Chokroverty and Stanley Fahn

    Version of Record online : 23 MAY 2005, DOI: 10.1002/mds.870010206

  8. Sodium vaiproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia

    Acta Psychiatrica Scandinavica

    Volume 67, Issue 3, March 1983, Pages: 178–187, T. Friis, T. Rosted Christensen and J. Gerlach

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1983.tb00339.x

  9. Akathisia in Parkinson's disease

    Movement Disorders

    Volume 9, Issue 5, 1994, Pages: 545–549, Dr. Cynthia L. Comella and Christopher G. Goetz

    Version of Record online : 12 OCT 2004, DOI: 10.1002/mds.870090507

  10. Extrapyramidal symptoms and residual psychopathology with low-dose neuroleptics

    Human Psychopharmacology: Clinical and Experimental

    Volume 15, Issue 2, March 2000, Pages: 79–85, Domenico Berardi, Annalisa Giannelli, Roberto Biscione and Giuseppe Ferrari

    Version of Record online : 31 MAR 2000, DOI: 10.1002/(SICI)1099-1077(200003)15:2<79::AID-HUP146>3.0.CO;2-6

  11. Effect of clonazepam on tardive akathisia

    Human Psychopharmacology: Clinical and Experimental

    Volume 6, Issue 1, March 1991, Pages: 39–42, Masahiro Kuniyoshi, Katsuyoshi Arikawa, Chishin Miura and Kazutoyo Inanaga

    Version of Record online : 13 OCT 2004, DOI: 10.1002/hup.470060107

  12. Akathisia in neuroleptic medicated mentally handicapped subjects

    Journal of Intellectual Disability Research

    Volume 33, Issue 4, August 1989, Pages: 323–329, S. GANESH, J. MURTI RAO and V. A. COWIE

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2788.1989.tb01481.x

  13. Distinguishing Acute and Tardive Akathisia by Monitoring Microvibration: A Pilot Study

    Psychiatry and Clinical Neurosciences

    Volume 46, Issue 3, September 1992, Pages: 665–672, Tadashi Nishikawa, Hiroo Kuwahara, Akira Tsuda, Masatoshi Tanaka, Itsuyuki Koga and Yasunori Uchida

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1440-1819.1992.tb00541.x

  14. You have free access to this content
    Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic – what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

    International Journal of Clinical Practice

    Volume 69, Issue 9, September 2015, Pages: 978–997, L. Citrome

    Version of Record online : 6 AUG 2015, DOI: 10.1111/ijcp.12714

  15. Medication-Induced Movement Disorders

    Psychiatry, Third Edition

    Thomas W. Meeks, Dilip V. Jeste, Pages: 1773–1793, 2008

    Published Online : 8 AUG 2008, DOI: 10.1002/9780470515167.ch84

  16. Polypharmacy akathisia and associated suicide attempts

    Depression

    Volume 1, Issue 1, 1993, Pages: 53–55, Anand Popli and Sanjay Gupta

    Version of Record online : 2 JAN 2008, DOI: 10.1002/depr.3050010111

  17. Nocturnal akathisia in parkinson's disease: Treatment with clozapine

    Movement Disorders

    Volume 8, Issue 2, 1993, Pages: 171–174, Dr. G. Linazasoro, J. F. Martí Massó and J. A. Suárez

    Version of Record online : 12 OCT 2004, DOI: 10.1002/mds.870080209

  18. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dvskinesia

    Acta Psychiatrica Scandinavica

    Volume 93, Issue 6, June 1996, Pages: 451–459, P. Sachdev, F. Hume, P. Toohey and C. Doutney

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1996.tb10677.x

  19. Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: A generalization of Steen's study on DRD3 and tardive dyskinesia

    American Journal of Medical Genetics

    Volume 96, Issue 2, 3 April 2000, Pages: 187–191, P. Eichhammer, M. Albus, M. Borrmann-Hassenbach, A. Schoeler, A. Putzhammer, U. Frick, H.E. Klein and T. Rohrmeier

    Version of Record online : 13 APR 2000, DOI: 10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8

  20. Usefulness of Antiparkinsonian Drugs during Neuroleptic Treatment and the Effect of Clonazepam on Akathisia and Parkinsonism Occurred after Antiparkinsonian Drug Withdrawal: A Double-Blind Study

    Psychiatry and Clinical Neurosciences

    Volume 46, Issue 3, September 1992, Pages: 733–739, Jun Horiguchi and Ohichi Nishimatsu

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1440-1819.1992.tb00549.x